Lori Marini

1.9k total citations
10 papers, 193 citations indexed

About

Lori Marini is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Lori Marini has authored 10 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Lori Marini's work include Advanced Breast Cancer Therapies (4 papers), Cancer Genomics and Diagnostics (4 papers) and HER2/EGFR in Cancer Research (2 papers). Lori Marini is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer Genomics and Diagnostics (4 papers) and HER2/EGFR in Cancer Research (2 papers). Lori Marini collaborates with scholars based in United States, India and Italy. Lori Marini's co-authors include Utthara Nayar, Samuel S. Freeman, Seth A. Wander, Eric P. Winer, Ofir Cohen, Nancy U. Lin, Nikhil Wagle, Karla Helvie, X. Cynthia and Aviv Regev and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Lori Marini

9 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Marini United States 4 127 95 71 58 22 10 193
Pablo Tolosa Spain 8 154 1.2× 91 1.0× 50 0.7× 61 1.1× 30 1.4× 36 229
Rhiannon Coulson Australia 5 91 0.7× 72 0.8× 32 0.5× 73 1.3× 8 0.4× 6 157
Faye Su United States 5 120 0.9× 133 1.4× 54 0.8× 46 0.8× 5 0.2× 16 171
Beatrice Taurelli Salimbeni Italy 8 139 1.1× 81 0.9× 84 1.2× 69 1.2× 29 1.3× 27 232
Claudette Falato Spain 10 161 1.3× 78 0.8× 107 1.5× 78 1.3× 25 1.1× 20 261
Guangnan Wei China 6 127 1.0× 59 0.6× 97 1.4× 71 1.2× 39 1.8× 11 209
Andy Futreal United States 6 87 0.7× 41 0.4× 53 0.7× 134 2.3× 19 0.9× 10 225
Mengxi Ge China 8 144 1.1× 183 1.9× 108 1.5× 97 1.7× 9 0.4× 15 281
Benjamin Tanenbaum United States 5 48 0.4× 48 0.5× 55 0.8× 130 2.2× 10 0.5× 6 191
IA Mayer United States 9 236 1.9× 170 1.8× 66 0.9× 88 1.5× 43 2.0× 25 297

Countries citing papers authored by Lori Marini

Since Specialization
Citations

This map shows the geographic impact of Lori Marini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Marini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Marini more than expected).

Fields of papers citing papers by Lori Marini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Marini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Marini. The network helps show where Lori Marini may publish in the future.

Co-authorship network of co-authors of Lori Marini

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Marini. A scholar is included among the top collaborators of Lori Marini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Marini. Lori Marini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Marini, Lori, et al.. (2024). Synthesis, characterization, and biosensing performance of cobalt sulphide reinforced polyaniline composites. Physica B Condensed Matter. 679. 415761–415761. 1 indexed citations
3.
Marini, Lori, et al.. (2024). Edge-functionalized coal-derived graphene oxide in bacterial nanocellulose hydrogel for active wound healing. International Journal of Biological Macromolecules. 272(Pt 1). 132589–132589. 5 indexed citations
4.
Marini, Lori, et al.. (2024). Screen Printable, Sustainable Water-Based Functional Ink From Coal-Derived Reduced Graphene Oxide for Humidity Sensing. IEEE Sensors Letters. 9(1). 1–4. 2 indexed citations
5.
Nayar, Utthara, Ofir Cohen, Michael S. Cuoco, et al.. (2018). Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies. Nature Genetics. 51(2). 207–216. 159 indexed citations
6.
Wander, Seth A., Ofir Cohen, Gabriela N. Johnson, et al.. (2018). Whole exome sequencing (WES) in hormone-receptor positive (HR+) metastatic breast cancer (MBC) to identify mediators of resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i).. Journal of Clinical Oncology. 36(15_suppl). 12016–12016. 11 indexed citations
7.
Nayar, Utthara, Ofir Cohen, Adrienne G. Waks, et al.. (2018). Abstract 4952: Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to ER-directed therapies. Cancer Research. 78(13_Supplement). 4952–4952. 2 indexed citations
8.
Wagle, Nikhil, Karla Helvie, Maxwell R. Lloyd, et al.. (2016). A cancer precision medicine platform for multiple simultaneous genomic assays from metastatic biopsies (bx) in ER+ metastatic breast cancer.. Journal of Clinical Oncology. 34(15_suppl). 11513–11513.
9.
Waks, Adrienne G., Ofir Cohen, Karla Helvie, et al.. (2016). Mechanisms of resistance (MoR) to DNA damaging therapy (tx) in BRCA1/2-deficient (d) metastatic breast cancer (MBC).. Journal of Clinical Oncology. 34(15_suppl). 542–542. 1 indexed citations
10.
Silvestris, Nicola, Modesto DʼAprile, Giovanna Andreola, et al.. (2004). Rationale for the use of gemcitabine in breast cancer (Review). International Journal of Oncology. 24(2). 389–98. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026